UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 125

Sortiert nach

Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics

Breast cancer research and treatment, 2012-02, Vol.131 (3), p.827-836

2012

Link zum Volltext

Verfügbarkeit prüfen

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

Annals of surgical oncology, 2010-09, Vol.17 (9), p.2411-2418

2010

Link zum Volltext

Verfügbarkeit prüfen

Management of the axilla after neoadjuvant chemotherapy for breast cancer

British journal of surgery, 2019-11, Vol.106 (12), p.1571-1573

Vrancken Peeters, M. T. F. D.

2019

Link zum Volltext

Verfügbarkeit prüfen

Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure

Annals of surgical oncology, 2018-06, Vol.25 (6), p.1512-1520

2018

Link zum Volltext

Verfügbarkeit prüfen

Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence

Breast cancer research and treatment, 2022-08, Vol.194 (3), p.617-627

2022

Link zum Volltext

Verfügbarkeit prüfen

Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands

Breast cancer research and treatment, 2020-08, Vol.182 (3), p.709-718

2020

Link zum Volltext

Verfügbarkeit prüfen

Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer

British journal of surgery, 2010-08, Vol.97 (8), p.1226-1231

2010

Link zum Volltext

Verfügbarkeit prüfen

Radioactive seed localization in breast cancer treatment

British journal of surgery, 2016-01, Vol.103 (1), p.70-80

2016

Link zum Volltext

Verfügbarkeit prüfen

Combined PET–CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node‐positive breast cancer after neoadjuvant therapy

British journal of surgery, 2017-08, Vol.104 (9), p.1188-1196

2017

Link zum Volltext

Verfügbarkeit prüfen

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

European journal of nuclear medicine and molecular imaging, 2012-12, Vol.39 (12), p.1830-1838

2012

Link zum Volltext

Verfügbarkeit prüfen

Nationwide population‐based study of the impact of immediate breast reconstruction after mastectomy on the timing of adjuvant chemotherapy

British journal of surgery, 2019-11, Vol.106 (12), p.1640-1648

2019

Link zum Volltext

Verfügbarkeit prüfen

Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy

Annals of oncology, 2011-04, Vol.22 (4), p.870-876

2011

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure

Breast cancer research and treatment, 2015-08, Vol.153 (1), p.145-152

2015

Link zum Volltext

Verfügbarkeit prüfen

Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era

Annals of surgery, 2018-12, Vol.268 (6), p.1084-1090

2018

Link zum Volltext

Verfügbarkeit prüfen

Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET

Journal of Oncology, 2012, Vol.2012, p.438647-8

2012

Link zum Volltext

Verfügbarkeit prüfen

Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)

Breast (Edinburgh), 2018-08, Vol.40, p.76-81

2018

Link zum Volltext

Verfügbarkeit prüfen

The effect of being informed on receiving immediate breast reconstruction in breast cancer patients

European journal of surgical oncology, 2018-05, Vol.44 (5), p.717-724

2018

Link zum Volltext

Verfügbarkeit prüfen

Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands

Breast (Edinburgh), 2017-08, Vol.34, p.96-102

2017

Link zum Volltext

Verfügbarkeit prüfen

The intraoperative assessment of sentinel nodes – Standards and controversies

Breast (Edinburgh), 2017-08, Vol.34, p.S64-S69

2017

Link zum Volltext

Verfügbarkeit prüfen

Low Risk of Development of a Regional Recurrence After an Unsuccessful Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence

Annals of surgical oncology, 2019-08, Vol.26 (8), p.2417-2427

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of Second Opinions in Breast Cancer Diagnostics and Treatment: A Retrospective Analysis

Annals of surgical oncology, 2019-12, Vol.26 (13), p.4355-4363

2019

Link zum Volltext

Verfügbarkeit prüfen

Current decisions on neoadjuvant chemotherapy for early breast cancer: Experts’ experiences in the Netherlands

Patient education and counseling, 2018-12, Vol.101 (12), p.2111-2115

2018

Link zum Volltext

Verfügbarkeit prüfen

Large variation between hospitals in immediate breast reconstruction rates after mastectomy for breast cancer in the Netherlands

Journal of plastic, reconstructive & aesthetic surgery, 2017-02, Vol.70 (2), p.215-221

2017

Link zum Volltext

Verfügbarkeit prüfen

Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit

Breast (Edinburgh), 2017-12, Vol.36, p.34-38

2017

Link zum Volltext

Verfügbarkeit prüfen

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: A comparison to conventional imaging techniques

European journal of surgical oncology, 2010-04, Vol.36 (4), p.387-392

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(125)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(106)
Life Sciences & Biomedicine
(104)
Humans
(76)
Female
(75)
Oncology
(75)
Breast Cancer
(70)
Surgery
(50)
Middle Aged
(49)
Adult
(43)
Aged
(43)
Breast Neoplasms - Pathology
(36)
Breast Neoplasms - Surgery
(35)
Medicine
(32)
Medicine & Public Health
(31)
Neoplasm Staging
(28)
Tumors
(27)
Breast Neoplasms - Diagnostic Imaging
(26)
Neoadjuvant Therapy
(25)
Breast Neoplasms - Drug Therapy
(22)
Patients
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

Management of the axilla after neoadjuvant chemotherapy for breast cancer

Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure

Added value of repeat sentinel lymph node biopsy in FDG-PET/CT node-negative patients with ipsilateral breast cancer recurrence

Breast-contour preserving procedures for early-stage breast cancer: a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands

Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer

Radioactive seed localization in breast cancer treatment

Combined PET–CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node‐positive breast cancer after neoadjuvant therapy

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

Nationwide population‐based study of the impact of immediate breast reconstruction after mastectomy on the timing of adjuvant chemotherapy

Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy

The prognostic value of the neoadjuvant response index in triple-negative breast cancer: validation and comparison with pathological complete response as outcome measure

Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era

Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET

Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)

The effect of being informed on receiving immediate breast reconstruction in breast cancer patients

Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands

The intraoperative assessment of sentinel nodes – Standards and controversies

Low Risk of Development of a Regional Recurrence After an Unsuccessful Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence

Impact of Second Opinions in Breast Cancer Diagnostics and Treatment: A Retrospective Analysis

Current decisions on neoadjuvant chemotherapy for early breast cancer: Experts’ experiences in the Netherlands

Large variation between hospitals in immediate breast reconstruction rates after mastectomy for breast cancer in the Netherlands

Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: A comparison to conventional imaging techniques

Suchergebnisse filtern